Lonza · 15 hours ago
QC Analyst III - Microbiology
Portsmouth, NH
Full-time
Onsite
Mid LevelLonza is a global leader in life sciences operating across five continents. The QC Analyst III supports in-process, lot release, and stability testing for customer drug products while providing technical expertise and training within the Quality Control Microbiology team.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Perform microbial testing in support of in-process, lot release, and customer stability studies
Support utility, environmental, and HVAC monitoring and sampling throughout the facility
Review assays, test data, and documentation, identifying deviations and ensuring compliance with procedures
Author quality records and documentation, including deviations, CAPAs, change controls, and test methods
Train and mentor other analysts, supporting skill development and consistent laboratory execution
Lead and support projects such as method transfers, new instrument implementation, and method qualification activities
Apply cGMP and Data Integrity principles in all aspects of work in accordance with Lonza policies and procedures
Qualification
Required
Experience performing microbiology testing in a cGMP-regulated Quality Control laboratory
Demonstrated ability to recognize deviations from accepted practices and evaluate data of moderate complexity
Experience with quality systems and laboratory platforms such as LIMS and TrackWise
Strong written and verbal communication skills, including the ability to present information and train others
Proven ability to plan, prioritize, and lead tasks or projects within defined timelines
Proficiency with Microsoft Office and laboratory computer systems
Self-motivated team player with strong judgment, accountability, and commitment to quality
Benefits
Medical, dental and vision insurance
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Founded in 1897
10001+ employees
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Leadership Team
Wolfgang Wienand
Chief Executive Officer
Alfons Ehinger
Founder
Recent News
2026-01-07
2026-01-05
Company data provided by crunchbase